- Published on
KembaraXtra-Medicine – Atopic Dermatitis (Eczema)
Atopic dermatitis is a chronic inflammatory skin condition characterized by intense itching and recurrent eczematous flares. It is commonly associated with a personal or family history of allergic diseases such as asthma, food allergies, and allergic rhinitis, a constellation referred to as atopy.
The disease typically presents early in life, with many cases beginning within the first year, most often between three and six months of age. Children with widespread atopic dermatitis are at increased risk of later developing asthma and allergic rhinitis, a progression known as the atopic march. Although common in childhood, atopic dermatitis may persist into adulthood or recur after periods of remission.
Clinically, atopic dermatitis evolves through acute, subacute, and chronic phases. Acute disease presents with erythematous papules or plaques that may ooze and crust. Subacute disease is marked by dry, scaly, erythematous lesions, while chronic disease leads to skin thickening and lichenification as a result of repeated scratching. Pruritus is the most prominent and burdensome symptom at all stages.
The distribution of lesions varies with age. In infants and young children, lesions commonly involve the cheeks, face, neck, trunk, and extensor surfaces of the limbs. In older children and adults, the disease predominantly affects flexural areas such as the antecubital and popliteal fossae, with sparing of the groin. In adults, involvement of the hands, especially the dorsal hands and fingers, is particularly common.
Diagnosis is primarily clinical and based on characteristic features including pruritus, typical morphology and distribution, chronic or relapsing course, and a personal or family history of atopy. Minor features such as xerosis, elevated immunoglobulin E levels, and recurrent skin infections may support the diagnosis. Laboratory testing is usually unnecessary, and skin biopsy is reserved for atypical or treatment-resistant cases.
Management centers on restoring and maintaining the skin barrier and controlling inflammation. Daily skin care with regular use of emollients, particularly immediately after bathing, is essential. Baths or showers should be brief and lukewarm, and fragrance-free cleansers and detergents are recommended. Avoidance of known triggers such as heat, sweating, harsh soaps, wool, stress, and environmental allergens is an important preventive strategy.
Topical corticosteroids remain the first-line treatment for disease flares, with potency selected according to disease severity and body site. Low-potency steroids are preferred for the face and intertriginous areas, while medium- to high-potency agents may be used for thicker lesions on the trunk and extremities for limited durations. Topical calcineurin inhibitors serve as steroid-sparing agents, particularly for sensitive areas such as the face and skin folds.
Secondary bacterial skin infections, most commonly due to Staphylococcus aureus, should be treated promptly with appropriate antimicrobial therapy. Antihistamines do not directly treat the itch of atopic dermatitis but may be used at night to promote sleep and reduce scratching. In moderate to severe or refractory cases, phototherapy, systemic immunomodulatory agents, or targeted biologic therapy such as dupilumab may be required under specialist supervision.
The overall prognosis is favorable, with many children experiencing significant improvement or complete resolution by adolescence. However, atopic dermatitis often follows a relapsing and remitting course, and long-term management focuses on symptom control, prevention of flares, and maintenance of quality of life.
Atopic dermatitis is a chronic inflammatory skin condition characterized by intense itching and recurrent eczematous flares. It is commonly associated with a personal or family history of allergic diseases such as asthma, food allergies, and allergic rhinitis, a constellation referred to as atopy.
The disease typically presents early in life, with many cases beginning within the first year, most often between three and six months of age. Children with widespread atopic dermatitis are at increased risk of later developing asthma and allergic rhinitis, a progression known as the atopic march. Although common in childhood, atopic dermatitis may persist into adulthood or recur after periods of remission.
Clinically, atopic dermatitis evolves through acute, subacute, and chronic phases. Acute disease presents with erythematous papules or plaques that may ooze and crust. Subacute disease is marked by dry, scaly, erythematous lesions, while chronic disease leads to skin thickening and lichenification as a result of repeated scratching. Pruritus is the most prominent and burdensome symptom at all stages.
The distribution of lesions varies with age. In infants and young children, lesions commonly involve the cheeks, face, neck, trunk, and extensor surfaces of the limbs. In older children and adults, the disease predominantly affects flexural areas such as the antecubital and popliteal fossae, with sparing of the groin. In adults, involvement of the hands, especially the dorsal hands and fingers, is particularly common.
Diagnosis is primarily clinical and based on characteristic features including pruritus, typical morphology and distribution, chronic or relapsing course, and a personal or family history of atopy. Minor features such as xerosis, elevated immunoglobulin E levels, and recurrent skin infections may support the diagnosis. Laboratory testing is usually unnecessary, and skin biopsy is reserved for atypical or treatment-resistant cases.
Management centers on restoring and maintaining the skin barrier and controlling inflammation. Daily skin care with regular use of emollients, particularly immediately after bathing, is essential. Baths or showers should be brief and lukewarm, and fragrance-free cleansers and detergents are recommended. Avoidance of known triggers such as heat, sweating, harsh soaps, wool, stress, and environmental allergens is an important preventive strategy.
Topical corticosteroids remain the first-line treatment for disease flares, with potency selected according to disease severity and body site. Low-potency steroids are preferred for the face and intertriginous areas, while medium- to high-potency agents may be used for thicker lesions on the trunk and extremities for limited durations. Topical calcineurin inhibitors serve as steroid-sparing agents, particularly for sensitive areas such as the face and skin folds.
Secondary bacterial skin infections, most commonly due to Staphylococcus aureus, should be treated promptly with appropriate antimicrobial therapy. Antihistamines do not directly treat the itch of atopic dermatitis but may be used at night to promote sleep and reduce scratching. In moderate to severe or refractory cases, phototherapy, systemic immunomodulatory agents, or targeted biologic therapy such as dupilumab may be required under specialist supervision.
The overall prognosis is favorable, with many children experiencing significant improvement or complete resolution by adolescence. However, atopic dermatitis often follows a relapsing and remitting course, and long-term management focuses on symptom control, prevention of flares, and maintenance of quality of life.
0 Comments
